1. Home
  2. TENX vs DSS Comparison

TENX vs DSS Comparison

Compare TENX & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • DSS
  • Stock Information
  • Founded
  • TENX 1967
  • DSS 1984
  • Country
  • TENX United States
  • DSS United States
  • Employees
  • TENX N/A
  • DSS N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • DSS Containers/Packaging
  • Sector
  • TENX Health Care
  • DSS Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • DSS Nasdaq
  • Market Cap
  • TENX 11.4M
  • DSS 9.1M
  • IPO Year
  • TENX N/A
  • DSS N/A
  • Fundamental
  • Price
  • TENX $4.94
  • DSS $1.12
  • Analyst Decision
  • TENX Strong Buy
  • DSS
  • Analyst Count
  • TENX 4
  • DSS 0
  • Target Price
  • TENX $20.67
  • DSS N/A
  • AVG Volume (30 Days)
  • TENX 96.4K
  • DSS 25.4K
  • Earning Date
  • TENX 11-13-2024
  • DSS 11-13-2024
  • Dividend Yield
  • TENX N/A
  • DSS N/A
  • EPS Growth
  • TENX N/A
  • DSS N/A
  • EPS
  • TENX N/A
  • DSS N/A
  • Revenue
  • TENX N/A
  • DSS $19,276,000.00
  • Revenue This Year
  • TENX N/A
  • DSS N/A
  • Revenue Next Year
  • TENX N/A
  • DSS N/A
  • P/E Ratio
  • TENX N/A
  • DSS N/A
  • Revenue Growth
  • TENX N/A
  • DSS N/A
  • 52 Week Low
  • TENX $2.77
  • DSS $1.05
  • 52 Week High
  • TENX $41.92
  • DSS $3.46
  • Technical
  • Relative Strength Index (RSI)
  • TENX 64.74
  • DSS 38.87
  • Support Level
  • TENX $4.50
  • DSS $1.05
  • Resistance Level
  • TENX $5.09
  • DSS $1.18
  • Average True Range (ATR)
  • TENX 0.27
  • DSS 0.07
  • MACD
  • TENX 0.01
  • DSS -0.02
  • Stochastic Oscillator
  • TENX 81.01
  • DSS 20.00

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

Share on Social Networks: